• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Allergan Inc. - Articles and news items

The Top 21…wealthiest pharma companies

Blog, Z Homepage promo / 6 February 2017 / Niamh Marriott, Digital Editor

Find out who made it to the top of our list of richest pharma companies…

FDA clearance for Allergan’s refractory glaucoma treatment

Industry news / 5 December 2016 / Niamh Louise Marriott, Digital Editor

The XEN Glaucoma Treatment System reduces intraocular pressure in patients and is indicated for the management of refractory glaucomas…

Allergan acquires Motus following positive diabetic gastroparesis trial

Industry news / 28 October 2016 / Niamh Louise Marriott, Digital Content Producer

Results of a Phase 2b trial of relamorelin, Motus’ ghrelin agonist, for the treatment of gastroparesis in diabetics has led to Allergan acquiring Motus…

MedImmune out-licenses inflammatory diseases medicine to Allergan

Industry news / 3 October 2016 / Niamh Louise Marriott, Digital Content Producer

MEDI2070 is an IL-23 monoclonal antibody currently in a Phase IIb trial for Crohn’s disease (a chronic inflammatory disease of the intestines) and is…

Allergen receives positive opinion for IBS drug

Industry news / 26 July 2016 / Niamh Louise Marriott, Digital Content Producer

Trubberzi is an oral medication taken to relieve the main symptoms of irritable bowel syndrome with diarrhoea (IBS-D) in adults…

FDA approves expanded label for Namzaric in Alzheimer’s disease

Industry news / 20 July 2016 / Victoria White, Digital Content Producer

Namzaric is a fixed-dose combination of memantine hydrochloride, a NMDA receptor antagonist, and donepezil hydrochloride, an acetylcholinesterase inhibitor…

FDA approves Allergan’s hypertension drug Byvalson

Industry news / 7 June 2016 / Victoria White, Digital Content Producer

Byvalson is the first and only fixed-dose combination (FDC) of a beta blocker (BB) and angiotensin II receptor blocker (ARB) available in the US…

Allergan and Medicines360 donate IUDs in response to Puerto Rico Zika outbreak

Industry news / 1 June 2016 / Victoria White, Digital Content Producer

Allergan and Medicines360 are to donate 10,000 units of Liletta to the CDC Foundation in response to the Zika virus outbreak in Puerto Rico…

Ulipristal acetate meets primary endpoints in uterine fibroid study

Industry news / 9 May 2016 / Victoria White, Digital Content Producer

Allergan and Richter have announced positive results from Venus I, evaluating the efficacy and safety of ulipristal acetate in women with uterine fibroids…

Allergan’s $200 million expansion of its Waco facility gets underway

Industry news / 26 April 2016 / Victoria White, Digital Content Producer

Allergan has broken ground on a $200 million expansion of its Texas Waco facility that will nearly double its current footprint when completed…

Allergan acquires topical dermatology company Topokine Therapeutics

Industry news / 22 April 2016 / Victoria White, Digital Content Producer

Allergan has acquired Topokine Therapeutics for an upfront payment of $85 million and success-based development and sales milestones for XAF5…

Allergan and Pfizer terminate merger agreement

Industry news / 6 April 2016 / Victoria White

The decision was driven by the actions announced by the US Department of Treasury, which the companies concluded qualified as an “Adverse Tax Law Change”…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +